These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18456680)

  • 41. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades.
    Manna P; Sinha M; Sil PC
    Chem Biol Interact; 2009 Oct; 181(3):297-308. PubMed ID: 19682444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcription factors in the pathogenesis of diabetic nephropathy.
    Sanchez AP; Sharma K
    Expert Rev Mol Med; 2009 Apr; 11():e13. PubMed ID: 19397838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.
    Navarro-González JF; Jarque A; Muros M; Mora C; García J
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evaluation of renal biopsy in type-II diabetic patients.
    Arif M; Arif MK; Arif MS
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):627-31. PubMed ID: 19811713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tubulo-interstitial changes in glomerulopathy. II. Prognostic significance.
    Okoń K
    Pol J Pathol; 2003; 54(3):163-9. PubMed ID: 14703282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathology of diabetic nephropathy].
    Kanauchi M; Shiiki H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():270-4. PubMed ID: 12430240
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diabetic nephropathy].
    Morin C
    Union Med Can; 1968 Nov; 97(11):1609-12. PubMed ID: 5746559
    [No Abstract]   [Full Text] [Related]  

  • 51. [Erythropoietin--a novel marker reflecting the severity of tubulointerstitial damage in diabetic nephropathy].
    Inomata S; Mori H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():232-6. PubMed ID: 9513421
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunolocalization of laminin in diabetic nephropathy renal biopsy sections.
    Mukhtar A
    Panminerva Med; 1999 Sep; 41(3):275. PubMed ID: 10568131
    [No Abstract]   [Full Text] [Related]  

  • 53. Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis.
    Christensen EI; Verroust PJ
    Kidney Int; 2008 Nov; 74(10):1233-6. PubMed ID: 18974759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex tubular flow in the acutely obstructed kidney.
    Bretland PM
    Med Hypotheses; 1976; 2(3):107-11. PubMed ID: 940506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury.
    Kanauchi M; Nishioka M; Dohi K
    Diabetologia; 2000 Aug; 43(8):1076-7. PubMed ID: 10990088
    [No Abstract]   [Full Text] [Related]  

  • 56. [Etiopathogenesis of diabetic nephropathy].
    Tison P; Fet'kovskă N
    Vnitr Lek; 1983 Jan; 29(1):58-65. PubMed ID: 6338657
    [No Abstract]   [Full Text] [Related]  

  • 57. DIABETIC NEPHROPATHY: CLINICOPATHOLOGIC CORRELATION. A STUDY BASED ON RENAL BIOPSIES.
    SALOMON M
    Metabolism; 1963 Aug; 12():687-703. PubMed ID: 14062114
    [No Abstract]   [Full Text] [Related]  

  • 58. Caspases, Cell Death and Diabetic Nephropathy.
    Bălăşescu E; Ion DA; Cioplea M; Zurac S
    Rom J Intern Med; 2015; 53(4):296-303. PubMed ID: 26939205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy.
    Praga M
    Nephrol Dial Transplant; 2005 Dec; 20(12):2594-7. PubMed ID: 16223782
    [No Abstract]   [Full Text] [Related]  

  • 60. [Diabetes mellitus and renal tubule functions].
    Rebsomen L; Raccah D; Tsimaratos M
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S28-31. PubMed ID: 17378137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.